EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Pancreatic hepatoid adenocarcinoma with neuroendocrine differentiation and elevated AFP: a case report

Zhouliang Yang, Ting Li, Xiaowei Zhang

Frontiers in Oncology · 18.08.2025 · 15

DOI: 10.3389/fonc.2025.1652925 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Oncology, online erschienen am 18.08.2025. Verfasst von Zhouliang Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The First People's Hospital of Yongkang, Yongkang, Zhejiang, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatoid adenocarcinoma (HAC) of the pancreas is a rare malignant tumor characterized by morphologic and immunophenotypic features resembling hepatocellular carcinoma. The tumor cells exhibit polygonal morphology with eosinophilic or clear cytoplasm and large, irregular nuclei. Immunophenotypically, the tumor cells are positive for alpha-fetoprotein (AFP) and glypican-3. Pancreatic HAC is rare, and neuroendocrine differentiation often complicates both diagnosis and treatment. Case description We report a case of pancreatic HAC with neuroendocrine differentiation and elevated AFP levels. A 46-year-old man was hospitalized due to progressive jaundice and dark urine that persisted for a week. Physical examination revealed bile duct dilation, a pancreatic head mass, and markedly increased AFP levels. The patient, with a history of schizophrenia and lung cancer surgery 2 years prior, was on regular medication. Following a pancreaticoduodenectomy, postoperative monitoring indicated normalization of AFP levels.

Conclusion

Elevated serum AFP levels may be a crucial indicator for preoperative pancreatic HAC diagnosis. Additionally, pancreatic HAC has unique histological and immunophenotypic characteristics. However, neuroendocrine differentiation complicates diagnosis and treatment. Therefore, complete surgical resection is the optimal treatment option for this condition.

Schlagwörter

Stichwörter der Autor:innen

alpha-fetoproteinhepatocellular adenocarcinomaneuroendocrine differentiationpancreatic cancerrare tumorssurgical resection

Autor:innen und Institutionen

  • Department of Pathology, The First People's Hospital of Yongkang, Yongkang, Zhejiang, China.
  • Department of Imaging Medicine, The First People's Hospital of Yongkang, Yongkang, Zhejiang, China.
  • Department of Pathology, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, Zhejiang, China.

Zitieren

APA

Yang, Z., Li, T., & Zhang, X. (2025). Pancreatic hepatoid adenocarcinoma with neuroendocrine differentiation and elevated AFP: a case report. Frontiers in Oncology, 15. https://doi.org/10.3389/fonc.2025.1652925

Vancouver

Yang Z, Li T, Zhang X. Pancreatic hepatoid adenocarcinoma with neuroendocrine differentiation and elevated AFP: a case report. Frontiers in Oncology. 2025;15. doi:10.3389/fonc.2025.1652925

BibTeX
@article{Yang2025,
  author = {Yang, Zhouliang and Li, Ting and Zhang, Xiaowei},
  title = {Pancreatic hepatoid adenocarcinoma with neuroendocrine differentiation and elevated AFP: a case report},
  journal = {Frontiers in Oncology},
  year = {2025},
  volume = {15},
  doi = {10.3389/fonc.2025.1652925}
}
Kostenlos starten →